The Adaptogen Market: Numbers Tell the Story
Adaptogens — plant-based compounds used in traditional medicine to support the body's stress response — have become one of the fastest-growing segments in the supplement market. As of 2024, the global adaptogen market is estimated at approximately $4 billion.
But what exactly is happening in Europe?
European Market Overview
The European adaptogen market follows US trends with roughly a 2-year lag, but is now growing robustly.
Market Share by Adaptogen
| Adaptogen | Market Share (est.) | Growth | Popularity |
|---|---|---|---|
| Ashwagandha | ~40%+ | Fast | #1 globally |
| Rhodiola rosea | ~15% | Steady | Especially popular in Nordics |
| Cordyceps | ~12% | Very fast | Growing in sports segment |
| Reishi | ~10% | Moderate | Immunity segment |
| Lion's mane | ~8% | Very fast | Cognitive segment |
| Others | ~15% | Varies | Maca, tulsi, eleuthero etc. |
What Is Driving Growth?
Several trends are fuelling the popularity of adaptogens in Europe:
1. Stress management — post-pandemic health-conscious consumers seek natural stress relief
2. Mental performance — interest in supporting cognitive function at work and in sport
3. Natural alternatives — consumers prefer plant-based solutions
4. Social media influence — health influencers introduce adaptogens to wider audiences
5. Scientific evidence base — a growing body of research builds trust
Ashwagandha: The Market-Dominating Adaptogen
Ashwagandha (Withania somnifera) is arguably the most popular adaptogen in the world.
Why ashwagandha dominates:
- The most clinical research (~25+ randomised controlled trials) (Bonilla et al., 2022)
- Standardised extracts (KSM-66, Sensoril) build confidence (Langade et al., 2019)
- Versatile use potential — stress, sleep, sport, general wellbeing
- Relatively affordable
Rhodiola: The Nordic Favourite
Rhodiola rosea is especially popular in the Nordic countries, where it has a long history of use.
Rhodiola strengths:
- Long traditional use in Scandinavian countries
- Studies suggest anti-fatigue properties (Darbinyan et al., 2000)
- EMA (European Medicines Agency) recognises rhodiola as a "traditional herbal medicinal product"
- Popular for supporting mental performance
Cordyceps: The Sports Segment
Cordyceps is a fast-growing adaptogen, particularly among athletes and fitness enthusiasts.
Behind cordyceps growth:
- Association with endurance and performance
- Growing interest in mushroom extracts more broadly
- Cultivated Cordyceps militaris (not the rare, expensive wild C. sinensis)
- Intriguing (though limited) research on oxygen uptake (Hirsch et al., 2017)
EU Regulatory Landscape
Classification
Most adaptogens are classified as food supplements in the EU. Some important regulatory aspects:
- Novel Food: Some adaptogens are under Novel Food review, meaning their sale may be restricted until EFSA approval
- Health claims: EFSA has not approved health claims for most adaptogens (except some traditional herbal medicines)
- Quality standards: The EU requires GMP (Good Manufacturing Practice) compliance
- Nordic warnings: As noted, Iceland and Denmark have issued ashwagandha warnings
What Is Allowed and What Is Not?
Europe applies stricter rules than the US:
- Health claims may only be used with EFSA approval
- Manufacturers cannot claim a product "cures" or "supports overall health"
- Cautious language is required: "contributes to," "supports"
Consumer Trends
Clean Label and Standardised Extracts
European consumers increasingly prefer:
- Clean formulations — minimal additives
- Standardised extracts — precise active ingredient content
- Third-party testing — independent quality certification
- Sustainable sourcing — ethically sourced raw materials
Popular Formats
- Capsules and tablets remain the most popular
- Powders (added to smoothies, coffee)
- Functional drinks with adaptogens
- "Stack" products (multi-adaptogen blends)
What to Expect Going Forward?
The outlook for the European adaptogen market is optimistic, though challenges remain:
- Regulatory clarity — EFSA assessments could reshape the market
- Harmonisation of quality standards
- Results from a greater number of human studies
- Possible new adaptogens entering the mainstream (e.g. Turkesterone, schisandra)
References
1. Bonilla DA, Moreno Y, Rawson ES, et al. (2022). A systematic review and meta-analysis of randomized controlled trials on the effects of ashwagandha (Withania somnifera) supplementation on strength and body composition. Journal of the International Society of Sports Nutrition, 19(1), 336-365.
2. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. (2019). Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus, 11(9), e5797.
3. Darbinyan V, Kteyan A, Panossian A, et al. (2000). Rhodiola rosea in stress induced fatigue — a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen. Phytomedicine, 7(5), 365-371.
4. Hirsch KR, Smith-Ryan AE, Roelofs EJ, Trexler ET, Mock MG. (2017). Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation. Journal of Dietary Supplements, 14(1), 42-53.
---
Read more:
Disclaimer
Dietary supplements are not a substitute for a varied, balanced diet and healthy lifestyle.
